Brown Advisory Inc Alaunos Therapeutics, Inc. Transaction History

Brown Advisory Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$3.98 - $6.2 $345,018 - $537,465	-86,688 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$1.61 - $3.62 $122,314 - $275,018	-75,972 Reduced 46.71%	86,688 $162,000
Q1 2018 Jun 28, 2018	BUY	$3.46 - $5.14 $562,803 - $836,072	162,660 New	162,660 $638,000
Q1 2018 May 14, 2018	SELL	$3.46 - $5.14 $748,927 - $1.11 Million	-216,453 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	216,453	216,453 $1.35 Million

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.